Related Experiment Video
Updated: Jul 16, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
[Comment on the article: "Changes in the triglyceride-glucose index after one year of antiretroviral therapy"]
Gonzalo Enrique Flores-Guamán1
1Médico General. Cuenca, Ecuador.
Abstract:
Both HIV diagnosis and antiretroviral therapy (55.1%) increase the risk of developing lipid profile abnormalities. This has led the European Society of Cardiology, in its 2025 update on the management of dyslipidemias, to incorporate statin therapy in patients older than 40 years with an HIV diagnosis as primary prevention for atherosclerotic cardiovascular disease. These updates not only recommend strict control of the lipid profile in this population group, but also pharmacological therapy for the prevention of future cardiovascular events.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Retrovirus Life Cycles
